Overview
Interleukin-6 receptor (IL-6R) signaling is causally implicated in the susceptibility to atopic dermatitis 1. Genetic evidence indicates that pharmacological inhibition of the IL-6R pathway is associated with an increased risk of developing atopic skin disease (OR 1.78 per 4.4-mg/L reduction in C-reactive protein) 1.Special Populations
Key Recommendations
References
1 Zhao SS, Yiu ZZN. Genetically proxied IL-6 receptor inhibition is associated with increased risk of atopic dermatitis. The Journal of allergy and clinical immunology 2024. link